World-class treatment of Ischemic Heart Disease

Ischemic heart disease mortalities in Korea stand at 42 people per 100,000 population, extremely lower than the OECD average (122 people per 100,000 population)

The mortality rate due to ischemic heart disease in Korea has decreased by 60% on average since 1990 with the development of a revolutionary treatments.

Factors in the development of cardiac infarction treatment

• The introduction of CCU (Coronary Care Unit)
• The advancements in CABG (Coronary Artery Bypass Grafting) and PCI (Percutaneous Coronary Intervention)
• The development of state-of-the-art medical equipment and coronary stents

 

Establishment and operation of 11 designed Cardiac and Cerebral Vascular Disease Centers by the government

• Korean government established a plan for the 'Institution and Operation of Cardiac and Cerebral Vascular Disease Centers' in 2008
• Providing appropriate medical treatment to cardiovascular disease patients in the initial stage in timely manner so as to increase the treatment performance
• 96% of the patients takes less than 120 minutes, between arriving to an emergency room to receiving primary coronary angiography
• Cardio-Cerebrovascular disease centers have been in operation in 11 districts across the country (24-hour operation)
• Providing professional treatment services in a timely manner, including CP (Critical Pathway) development and distribution, and early rehabilitation